The Lynx Group
Association for Value-Based Care

AVBCC 2020 Summit

Uncertainty reigns in Washington with the upcoming election only weeks away. What can cancer care stakeholders expect from legislators and policymakers over the next several weeks, during the lame duck session, and in 2021?
Read More

The top priority for employers regarding their employees’ cancer care coverage is ensuring access to state-of-the-art care. Learn how employers are trying to close the gap between “typical” and “optimal” care.
Read More

Telling the story of the Oncology Care Model and its performance over the past 5 years through some of the best-performing practices.
Read More

On October 8, 2020, the Berkeley Research Group published a report showing that contract pharmacy participation in the 340B Drug Pricing Program grew by 4228% between 2010, when the Health Resources and Services Administration expanded the contract pharmacy program, and 2020. A week later, on October 16, 2020, a variety of stakeholders in the 340B program—covered entities, contract pharmacies, pharmaceutical manufacturers, and outside tech consultants—participated in an intense discussion of contract pharmacy growth, newly imposed manufacturer audit requirements, and ways to return 340B to its original purpose of spreading scarce federal resources and serving vulnerable patients.
Read More

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: